Publications by authors named "Annie-Rose Henry"
Cancers (Basel)
September 2024
Article Synopsis
- Stage IIIA-N2 non-small cell lung cancer (NSCLC) has low survival rates and lacks a standardized treatment, making patient management difficult.
- This study analyzed 142 patients to assess overall survival (OS) and disease-free survival (DFS), finding the median OS to be 31 months, with no significant differences between treatment methods.
- The results emphasize the need for personalized treatment plans and collaborative decision-making among healthcare professionals, with future research aimed at new therapies and multi-centre trials.
